• Clinical Insights: January 19, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval Enhertu® (fam-trastuzumab deruxtecan-nxki) Injection – New Approved Indication – January 15, 2021 – Daiichi Sankyo Company,… Read more »

  • Clinical Insights: January 12, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New/Updated Drug Shortage January 11, 2021 Dexmedetomidine Injection (Currently in Shortage) Tacrolimus Capsules… Read more »

  • Clinical Insights: January 5, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New/Updated Drug Shortage December 31, 2020 Cisatracurium Besylate Injection (Currently in Shortage) December… Read more »

  • Clinical Insights: December 29, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Gemtesa® (vibegron) Tablets – New Drug Approval – December 23, 2020 – Urovant Sciences announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug… Read more »

  • Clinical Insights: December 22, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OrgovyxTM (relugolix) Tablets – New Drug Approval – December 18, 2020 – Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced that… Read more »

  • Clinical Insights: December 15, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OrladeyoTM (berotralstat) Capsules – New Orphan Drug Approval – December 3, 2020 – BioCryst Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved oral,… Read more »

  • Clinical Insights: December 8, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Gallium 68 PSMA-11 (Ga 68 PSMA-11)  – New Drug Approval – December 1, 2020 – The U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11)… Read more »

  • Clinical Insights: December 1, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Imcivree®  (setmelanotide) Injection – New Drug Approval – November 27, 2020 – The U.S. Food and Drug Administration approved Imcivree®  (setmelanotide) for chronic weight management (weight loss and… Read more »

  • Clinical Insights: November 24, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ZokinvyTM (lonafarnib) Capsules – New Drug Approval – November 20, 2020 – The U.S. Food and Drug Administration approved ZokinvyTM (lonafarnib) capsules to reduce the risk of death… Read more »

  • Clinical Insights: November 17, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets – New Drug Approval – November 10, 2020 – Sebela Pharmaceuticals® announced that the U.S. Food and Drug Administration… Read more »